Hanall loses in lawsuit

Published: 2011-03-07 06:58:00

Updated: 2011-03-07 06:58:00

Hanall Pharmaceutical lost in a lawsuit the company filed against Baxter Korea for extending the distribution agreement of the latter’s amino acid infusion, which expired on December 31, 2010.

The Seoul District Court ruled Thursday that the agreement executed by Hanall and Baxter is legal, st...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK